ENSYSCE BIOSCIENCES, INC. Stock Redeemed or Called During Period, Shares
ENSYSCE BIOSCIENCES, INC. (ENSC) reported Stock Redeemed or Called During Period, Shares of 10.19 million shares for the 6-month period ending 2022-06-30, per its 10-Q filed 2022-08-11.
Discontinued › Shareholders' Equity
us-gaap:StockRedeemedOrCalledDuringPeriodShares · last filed 2022-08-11
- ENSYSCE BIOSCIENCES, INC. stock redeemed or called during period, shares for the quarter ending 2022-06-30 was 5.48M shares.
- ENSYSCE BIOSCIENCES, INC. stock redeemed or called during period, shares for the quarter ending 2022-03-31 was 4.71M shares.
- ENSYSCE BIOSCIENCES, INC. stock redeemed or called during period, shares for the quarter ending 2019-09-30 was -39.31K shares.
- ENSYSCE BIOSCIENCES, INC. stock redeemed or called during period, shares for the quarter ending 2019-06-30 was -52.35K shares.
- ENSYSCE BIOSCIENCES, INC. stock redeemed or called during period, shares for fiscal 2018 was 18.96M shares.
| Period end | Stock Redeemed or Called During Period, Shares 3 month | Stock Redeemed or Called During Period, Shares 4 month | Stock Redeemed or Called During Period, Shares 6 month | Stock Redeemed or Called During Period, Shares 9 month | Stock Redeemed or Called During Period, Shares 12 month |
|---|---|---|---|---|---|
| 2022-06-30 | 5.48M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | 10.19M shares 10-Q · filed 2022-08-11 | |||
| 2022-03-31 | 4.71M shares 10-Q · filed 2022-05-12 | ||||
| 2019-09-30 | -39.31K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | -91.66K shares derived: sum of 2 quarters · filed 2019-11-07 | 18.86M shares 10-Q · filed 2019-11-07 | 18.85M shares derived: sum of 4 quarters · filed 2019-11-07 | |
| 2019-06-30 | -52.35K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | 18.90M shares 10-Q · filed 2019-08-07 | 18.89M shares derived: sum of 3 quarters · filed 2019-08-07 | 18.87M shares derived: sum of 4 quarters · filed 2019-11-07 | |
| 2019-03-31 | 18.95M shares 10-Q · filed 2019-05-07 | 18.94M shares derived: sum of 2 quarters · filed 2019-05-07 | 18.92M shares derived: sum of 3 quarters · filed 2019-11-07 | 18.90M shares derived: sum of 4 quarters · filed 2019-11-07 | |
| 2018-12-31 | -13.23K shares derived: 10-K/A 12 month − 10-Q 9 month · filed 2019-03-12 | -28.92K shares derived: sum of 2 quarters · filed 2019-11-07 | -49.11K shares derived: sum of 3 quarters · filed 2019-11-07 | 18.96M shares 10-K/A · filed 2019-03-12 | |
| 2018-09-30 | -15.69K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | -35.88K shares derived: sum of 2 quarters · filed 2019-11-07 | 18.97M shares 10-Q · filed 2019-11-07 | ||
| 2018-06-30 | -20.19K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | 18.99M shares 10-Q · filed 2019-08-07 | |||
| 2018-03-31 | 19.01M shares 10-Q · filed 2019-05-07 | ||||
| 2017-12-31 | 19.02M shares 10-K/A · filed 2019-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |